OGT-mediated O-GlcNAcylation of TEAD1 at Serine 132 enhances TEAD1 stability and activity and contributes to atherosclerosis progression
Clinical Science · 2026
DOI: 10.1042/cs20261203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, 2026. Verfasst von Xiaojin Yin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Central People's Hospital of Ji'an, Ji'an, Jiangxi 343000, China. Hauptthemen laut MEDLINE: N-Acetylglucosaminyltransferases, DNA-Binding Proteins, Atherosclerosis, Transcription Factors. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), | Natural Science Foundation of Jiangxi Province (Jiangxi Natural Science Foundation), Ganpo Talent Program.
Abstract (Originalsprache)
Atherosclerosis is a leading cause of cardiovascular morbidity and mortality, yet the molecular mechanisms driving plaque progression remain incompletely understood. O-GlcNAc transferase (OGT) couples nutrient status to protein O-GlcNAcylation, but its vascular actions appear context-dependent. In an exploratory carotid endarterectomy cohort, OGT expression and global O-GlcNAcylation were higher in plaques obtained from symptomatic patients than in plaques from asymptomatic patients. In Western diet-fed ApoE−/− mice, inducible smooth muscle cell-specific OGT deletion was associated with lower aortic lesion burden, lower serum triglyceride and total cholesterol concentrations, and reduced plaque lipid and collagen areas. Proteomic screening identified TEAD1 (TEA domain transcription factor 1) as an O-GlcNAcylated protein enriched in clinically symptomatic human samples. OGT interacted with TEAD1 and promoted O-GlcNAcylation at Serine 132 (S132); mutation of this residue reduced TEAD1 stability, nuclear accumulation, and reporter activity. In a complementary human umbilical vein endothelial cell model, OGT knockdown limited oxidized low-density lipoprotein-induced injury, inflammation, monocyte adhesion, and endothelial-to-mesenchymal transition, whereas TEAD1 overexpression attenuated these effects. Smooth muscle-targeted TEAD1 overexpression also attenuated the lesion reduction associated with OGT deletion in vivo. These findings support an OGT–TEAD1 pathway in atherosclerosis while indicating that concurrent lipid changes, plaque-cell specificity, and the relative endothelial contribution require further resolution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Central People's Hospital of Ji'an, Ji'an, Jiangxi 343000, China.
- Department of Cardiology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.
ORCID-Profile: Tong Wen
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- | Natural Science Foundation of Jiangxi Province (Jiangxi Natural Science Foundation)
- Ganpo Talent Program
- 江西省科学技术厅 | Natural Science Foundation of Jiangxi Province
Zitieren
APA
Yin, X., Liu, Z., Gao, Z., Yan, H., Kuang, L., Guo, J., Zou, J., Wang, L., Chen, S., & Wen, T. (2026). OGT-mediated O-GlcNAcylation of TEAD1 at Serine 132 enhances TEAD1 stability and activity and contributes to atherosclerosis progression. Clinical Science. https://doi.org/10.1042/cs20261203
Vancouver
Yin X, Liu Z, Gao Z, Yan H, Kuang L, Guo J, et al. OGT-mediated O-GlcNAcylation of TEAD1 at Serine 132 enhances TEAD1 stability and activity and contributes to atherosclerosis progression. Clinical Science. 2026. doi:10.1042/cs20261203
BibTeX
@article{Yin2026,
author = {Yin, Xiaojin and Liu, Zhongwen and Gao, Zhenling and Yan, Hengming and Kuang, Linhua and Guo, Jugen and Zou, Jiamin and Wang, Liang and Chen, Shanshan and Wen, Tong},
title = {OGT-mediated O-GlcNAcylation of TEAD1 at Serine 132 enhances TEAD1 stability and activity and contributes to atherosclerosis progression},
journal = {Clinical Science},
year = {2026},
doi = {10.1042/cs20261203}
}
EUVIMED